Roles for SUMO modification during senescence

Advances in Experimental Medicine and Biology

Volumn 694, Issue , 2010, Pages 160-171

  Andreou, Artemisia M ^b   Tavernarakis, Nektarios ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN P53; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; SUMO PROTEIN; UBIQUITIN PROTEIN LIGASE E3; PROTEIN;

APOPTOSIS; ARTICLE; CELL AGING; CELL DIVISION; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CONJUGATION; DNA REPAIR; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SENESCENCE; SUMOYLATION; TELOMERE; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

MURINAE;

ANIMALS; CELL AGING; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

EID: 78049368535     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7002-2_12     Document Type: Article

References (119)

1. Bayer P, Arndt A, Metzger S et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol 1998; 280(2):275-286. (Pubitemid 28325519)
2. Jin C, Shiyanova T, Shen Z et al. Heteronuclear nuclear magnetic resonance assignments, structure and dynamics of SUMO-1, a human ubiquitin-like protein. Int J Biol Macromol 2001; 28(3):227-234. (Pubitemid 32197458)
3. Johnson ES. Protein modification by SUMO. Annu Rev Biochem 2004; 73:355-382. (Pubitemid 39050373)
4. Bohren KM, Nadkarni V, Song JH et al. A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J Biol Chem 2004; 279(26):27233-27238. (Pubitemid 38812561)
5. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 2000; 275(9):6252-6258. (Pubitemid 30129915)
6. Hay RT. SUMO: a history of modification. Mol Cell 2005; 18(1):1-12. (Pubitemid 40444643)
7. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev 2005; 15(5):536-541. (Pubitemid 41262410)
8. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 2001; 276(24):21664-21669.
9. Melchior F, Schergaut M, Pichler A. SUMO: ligases, isopeptidases and nuclear pores. Trends Biochem Sci 2003; 28(11):612-618. (Pubitemid 38352808)
10. Minty A, Dumont X, Kaghad M et al. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem 2000; 275(46):36316-36323.
11. Rodriguez MS, Dargemont C, Hay RT. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem 2001; 276(16):12654-12659.
12. Song J, Durrin LK, Wilkinson TA et al. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci USA 2004; 101(40):14373-14378. (Pubitemid 39346756)
13. Yang SH, Galanis A, Witty J et al. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 2006; 25(21):5083-5093. (Pubitemid 44658526)
14. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell 1998; 2(2):233-239. (Pubitemid 128373648)
15. Hoege C, Pfander B, Moldovan GL et al. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 2002; 419(6903):135-141. (Pubitemid 35025438)
16. Hietakangas V, Anckar J, Blomster HA et al. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 2006; 103(1):45-50. (Pubitemid 43076102)
17. Bossis G, Malnou CE, Farras R et al. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol 2005; 25(16):6964-6979. (Pubitemid 41105897)
18. Lin JY, Ohshima T, Shimotohno K. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett 2004; 573(1-3):15-18. (Pubitemid 39141028)
19. Muller S, Berger M, Lehembre F et al. c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem 2000; 275(18):13321-13329. (Pubitemid 30257389)
20. Girdwood D, Bumpass D, Vaughan OA et al. P300 transcriptional repression is mediated by SUMO modification. Mol Cell 2003; 11(4):1043-1054. (Pubitemid 36566325)
21. Yang SH, Sharrocks AD. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell 2004; 13(4):611-617. (Pubitemid 38299387)
22. Stankovic-Valentin N, Deltour S, Seeler J et al. An acetylation/ deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol 2007; 27(7):2661-2675. (Pubitemid 46581356)
23. Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 2003; 100(23):13225-13230. (Pubitemid 37444723)
24. Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 1999; 398(6724):246-251.
25. Li SJ, Hochstrasser M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol 2000; 20(7):2367-2377. (Pubitemid 30152045)
26. Azuma Y, Tan SH, Cavenagh MM et al. Expression and regulation of the mammalian SUMO-1 E1 enzyme. FASEB J 2001; 15(10):1825-1827.
27. Bailey D, O'Hare P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem 2004; 279(1):692-703. (Pubitemid 38044874)
28. Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci 2007; 32(6):286-295. (Pubitemid 46874931)
29. Bailey D, O'Hare P. Herpes simplex virus 1 ICP0 colocalizes with a SUMO-specific protease. J Gen Virol 2002; 83(Pt 12):2951-2964. (Pubitemid 36054340)
30. Gong L, Millas S, Maul GG et al. Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem 2000; 275(5):3355-3359. (Pubitemid 30083039)
31. Hang J, Dasso M. Association of the human SUMO-1 protease SENP2 with the nuclear pore. J Biol Chem 2002; 277(22):19961-19966. (Pubitemid 34967518)
32. Li SJ, Hochstrasser M. The Ulp1 SUMO isopeptidase: distinct domains required for viability, nuclear envelope localization and substrate specificity. J Cell Biol 2003; 160(7):1069-1081. (Pubitemid 36443875)
33. Gong L, Yeh ET. Characterization of a family of nucleolar SUMO-specific proteases with preference for SUMO-2 or SUMO-3. J Biol Chem 2006; 281(23):15869-15877. (Pubitemid 43848478)
34. Kim KI, Baek SH, Jeon YJ et al. A new SUMO-1-specific protease, SUSP1, that is highly expressed in reproductive organs. J Biol Chem 2000; 275(19):14102-14106. (Pubitemid 30339685)
35. Mukhopadhyay D, Ayaydin F, Kolli N et al. SUSP1 antagonizes formation of highly SUMO2/3- conjugated species. J Cell Biol 2006; 174(7):939-949. (Pubitemid 44455183)
36. Ayaydin F, Dasso M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 2004; 15(12):5208-5218. (Pubitemid 39564718)
37. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 2007; 8(12):947-956. (Pubitemid 350176509)
38. Papouli E, Chen S, Davies AA et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol Cell 2005; 19(1):123-133. (Pubitemid 40884663)
39. Pfander B, Moldovan GL, Sacher M et al. SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 2005; 436(7049):428-433. (Pubitemid 41059056)
40. Lin X, Sun B, Liang M et al. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 2003; 11(5):1389-1396. (Pubitemid 36645156)
41. Baba D, Maita N, Jee JG et al. Crystal structure of thymine DNA glycosylase conjugated to SUMO-1. Nature 2005; 435(7044):979-982. (Pubitemid 40896326)
42. Hardeland U, Steinacher R, Jiricny J et al. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J 2002; 21(6):1456-1464. (Pubitemid 34246524)
43. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621.
44. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001; 11(11): S27-31.
45. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002; 1(1):19-30. (Pubitemid 41039172)
46. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev 2008; 129(7-8):467-474.
47. Keyes WM, Wu Y, Vogel H et al. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 2005; 19(17):1986-1999. (Pubitemid 41247957)
48. Chen JH, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res 2007; 35(22):7417-7428.
49. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7(6):505-512. (Pubitemid 40799244)
50. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92(20):9363-9367.
51. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990; 249(4973):1129-1133.
52. Shay JW, Wright WE. Telomeres and telomerase: implications for cancer and aging. Radiat Res 2001; 155(1 Pt 2):188-193. (Pubitemid 33723537)
53. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000; 10(6):399-406. (Pubitemid 32181910)
54. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349):349-352. (Pubitemid 28063364)
55. Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000; 6(8):849-851. (Pubitemid 30644735)
56. Chang S, Multani AS, Cabrera NG et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004; 36(8):877-882. (Pubitemid 39014107)
57. Choudhury AR, Ju Z, Djojosubroto MW et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007; 39(1):99-105. (Pubitemid 46026508)
58. Serrano M, Blasco MA. Putting the stress on senescence. Curr Opin Cell Biol 2001; 13(6):748-753. (Pubitemid 33042736)
59. Ohtani N, Mann DJ, Hara E. Cellular senescence: its role in tumor suppression and aging. Cancer Sci2009; 100(5):792-797.
60. Hardy K, Mansfield L, Mackay A et al. Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell 2005; 16(2):943-953. (Pubitemid 40165583)
61. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 2007; 81(5):2102-2116.
62. Campisi J. Senescent cells, tumor supression and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-522. (Pubitemid 40269765)
63. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4(8):592-603. (Pubitemid 39025054)
64. Ben-Porath IaW RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004; 113:8-13.
65. Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 2002; 12:60-66. (Pubitemid 34094991)
66. Comerford KM, Leonard MO, Karhausen J et al. Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci USA 2003; 100(3):986-991. (Pubitemid 36183942)
67. Li T, Santockyte R, Shen RF et al. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 2006; 281:36221-36227. (Pubitemid 46041356)
68. Bischof O, DEjean A. SUMO is growing senescent. Cell Cycle 2007; 6:677-681. (Pubitemid 46535679)
69. Akar CA, Feinstein DL. Modulation of inducible nitric oxide synthase expression by sumoylation. J Neuroinflammation 2009; 6:12.
70. Li T, Evdokimov E, Shen RF et al. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins and nuclear pore complex proteins: a proteomic analysis. Proc Natl Acad Sci USA 2004; 101(23):8551-8556. (Pubitemid 38745808)
71. Gostissa M, Hengstermann A, Fogal V et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18:6462-6471. (Pubitemid 29533250)
72. Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor supressor. Oncogene 2005; 24:3810-3818. (Pubitemid 40826879)
73. Rodriguez M, Desterro JM, Lain S et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18:6455-6461. (Pubitemid 29533249)
74. Bischof O, Schwamborn K, Martin N et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 2006; 22(6):783-794.
75. Sugrue MM, Shin DY, Lee SW et al. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 1997; 97:9648-9653. (Pubitemid 27408116)
76. Schmidt DaM S. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 2003; 60:2561-2574.
77. Uchimura Y, Ichimura T, Uwada J et al. Involvement of SUMO modification in MBD1- and MCAF1- mediated heterochromatin formation. J Biol Chem 2006; 281:23180-23190.
78. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005; 7(6):505-512. (Pubitemid 40799244)
79. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92(20):9363-9367.
80. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science 1990; 249(4973):1129-1133.
81. Shay JW, Wright WE. Telomeres and telomerase: implications for cancer and aging. Radiat Res 2001; 155(1 Pt 2):188-193. (Pubitemid 33723537)
82. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000; 10(6):399-406. (Pubitemid 32181910)
83. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279(5349):349-352. (Pubitemid 28063364)
84. Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000; 6(8):849-851. (Pubitemid 30644735)
85. Chang S, Multani AS, Cabrera NG et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet 2004; 36(8):877-882. (Pubitemid 39014107)
86. Choudhury AR, Ju Z, Djojosubroto MW et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007; 39(1):99-105. (Pubitemid 46026508)
87. Serrano M, Blasco MA. Putting the stress on senescence. Curr Opin Cell Biol 2001; 13(6):748-753. (Pubitemid 33042736)
88. Ohtani N, Mann DJ, Hara E. Cellular senescence: its role in tumor suppression and aging. Cancer Sci2009; 100(5):792-797.
89. Hardy K, Mansfield L, Mackay A et al. Transcriptional networks and cellular senescence in human mammary fibroblasts. Mol Biol Cell 2005; 16(2):943-953. (Pubitemid 40165583)
90. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 2007; 81(5):2102-2116.
91. Campisi J. Senescent cells, tumor supression and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-522. (Pubitemid 40269765)
92. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 2004; 4(8):592-603. (Pubitemid 39025054)
93. Ben-Porath IaW RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004; 113:8-13.
94. Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 2002; 12:60-66. (Pubitemid 34094991)
95. Comerford KM, Leonard MO, Karhausen J et al. Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia. Proc Natl Acad Sci USA 2003; 100(3):986-991. (Pubitemid 36183942)
96. Li T, Santockyte R, Shen RF et al. Expression of SUMO-2/3 induced senescence through p53- and pRB-mediated pathways. J Biol Chem 2006; 281:36221-36227. (Pubitemid 46041356)
97. Bischof O, DEjean A. SUMO is growing senescent. Cell Cycle 2007; 6:677-681. (Pubitemid 46535679)
98. Akar CA, Feinstein DL. Modulation of inducible nitric oxide synthase expression by sumoylation. J Neuroinflammation 2009; 6:12.
99. Li T, Evdokimov E, Shen RF et al. Sumoylation of heterogeneous nuclear ribonucleoproteins, zinc finger proteins and nuclear pore complex proteins: a proteomic analysis. Proc Natl Acad Sci USA 2004; 101(23):8551-8556. (Pubitemid 38745808)
100. Gostissa M, Hengstermann A, Fogal V et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18:6462-6471. (Pubitemid 29533250)
101. Ledl A, Schmidt D, Muller S. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor supressor. Oncogene 2005; 24:3810-3818. (Pubitemid 40826879)
102. Rodriguez M, Desterro JM, Lain S et al. SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18:6455-6461. (Pubitemid 29533249)
103. Bischof O, Schwamborn K, Martin N et al. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 2006; 22(6):783-794.
104. Sugrue MM, Shin DY, Lee SW et al. Wild-type p53 triggers a rapid senescence program in humantumor cells lacking functional p53. Proc Natl Acad Sci USA 1997; 97:9648-9653. (Pubitemid 27408116)
105. Schmidt DaM S. PIAS/SUMO: new partners in transcriptional regulation. Cell Mol Life Sci 2003; 60:2561-2574.
106. Uchimura Y, Ichimura T, Uwada J et al. Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J Biol Chem 2006; 281:23180-23190.
107. Nathan D, Ingvarsdottir K, Sterner DE et al. Histone sumoylation is a negative regulator in Saccharomycesserevisiae and shown dynamic interplay with positive-acting histone modifications. Genes Dev 2006; 20:966-76.
108. Yates KE, Korbel GA, Shtutman M et al. Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 2008; 7(5):609-621.
109. de Lange T. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19:2100-2110. (Pubitemid 41330312)
110. Stewart SA, Weinberg RA. Telomeres: Cancer to human aging. Annu Rev Cell Dev Biol 2006; 22:531-557.
111. Tanaka K, Nishide J, Okazaki K et al. Characterization of a fission yeast SUMO-1 homologue, pmt3p, required for multiple nuclear events, including the control of telomere length and chromosome segregation. Mol Cell Biol 1999; 19:8660-8672. (Pubitemid 30414058)
112. Xhemalce B, Seeler JS, Thon G et al. Role of the fission yeast SUMO E3 ligase Pli1p in centromere and telomere maintenance. EMBO J 2004; 23:3844-3853. (Pubitemid 39389715)
113. Zhang L, Li F, Dimayuga E et al. Effects of aging and dietary restriction on ubiquitination, sumoylation and the proteasome in the spleen. FEBS Lett 2007; 581:5543-5547. (Pubitemid 350110436)
114. Wei F, Scholer HR, Atchison ML. Sumoylation od Oct4 enhances its stability, DNA binding and transactivation. J Biol Chem 2007; 282:21551-21560. (Pubitemid 47099909)
115. de Cristofaro T, Mascia A, Pappalardo A et al. Pax8 protein stability is controlled by sumoylation. J Mol Endocrinol 2009; 42:35-46.
116. Yurchenko V, Xue Z, Gama V et al. Ku70 is stabilized ny increased cellular SUMO. Biochem Biophys Res Commun 2008; 366:263-268. (Pubitemid 50010682)
117. Benanti J, Williams DK, Robinson KL et al. Induction of extracellular matrix-remodelling genes by the senescence-associated protein APA-1. Mol Cell Biol 2002; 22:7385-7397.
118. Cheng J, Kang X, Zhang S et al. SUMO-specific protease 1 is essential for stabilization of hypoxia-inducible factor-1a during hypoxia. Cell 2007; 131:584-595. (Pubitemid 350007694)
119. Wang YT, Chuang JY, Shen MR et al. Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process. J Mol Biol 2008; 380:869-885.